Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 143   

Articles published

GSK 1,635.00 -4.50 (-0.27%)
price chart
Could BP plc and GlaxoSmithKline plc help you retire early?
BP (LSE: BP) is one of the UK market's most trusted dividend stocks and so is its blue-chip peer GlaxoSmithKline (LSE: GSK). Together these two FTSE 100 dividend champions are are responsible for a huge chunk of the total value of dividends paid out to ...
GlaxoSmithKline PLC (GSK) Receives “Buy” Rating from Jefferies Group LLC  The Cerbat Gem
GlaxoSmithKline PLC (GSK) Given Buy Rating at Jefferies Group LLC  Chaffey Breeze
Drugs-crazed shoot-out: which investment is best out of Astra, Glaxo and Shire?
On a forward earnings multiple, again there is nothing between GSK and AZ (15 times 2017 EPS vs 15.6). Shire, however, comes in significantly cheaper at just 13 times - with that comes underlying earnings growth of 11% this year.
Are shares in GlaxoSmithKline plc now in bargain territory?
Shares in FTSE 100 pharmaceutical giant GlaxoSmithKline (LSE: GSK) were in the red this afternoon. That was despite the company reporting a 21% rise in sales (in sterling terms) over the fourth quarter and “continued momentum” in 2016 as a whole.
GSK a 'decent risk-reward trade'; shares could top �17
GlaxoSmithKline plc (LON:GSK) shares are on track to re-test their previous 52-week highs of over �17, according to technical analyst Zak Mir.
Glaxo braces itself for �1bn Advair hit
GlaxoSmithKline plc (LON:GSK) expects to make further progress this year, but warned over the possible impact of generic competition to its Advair asthma drug stateside.
GlaxoSmithKline Plc (GSK) Q4 2016 Results - Earnings Call Transcript  Seeking Alpha
GlaxoSmithKline Up Slightly After Results (GSK)  Investopedia
GSK announces positive study results for HIV treatment
The study, carried out by GSK's majority owned ViiV Healthcare business, showed the two drug treatment for HIV-1 was just as effective as the three or four drug regimens in virologically suppressed patients.
GlaxoSmithKline plc (ADR)(NYSE:GSK) Two-Drug Cocktail Aims Decrease HIV ...  Market Exclusive
Form 6-K GLAXOSMITHKLINE PLC For: Feb 14  StreetInsider.com
GlaxoSmithKline plc 21% Potential Upside Indicated by Liberum Capital
GlaxoSmithKline plc using EPIC/TICKER code LON:GSK has had its stock rating noted as 'Reiterates' with the recommendation being set at 'BUY' today by analysts at Liberum Capital.
GlaxoSmithKline plc (GSK) Earns Buy Rating from Beaufort Securities  Sports Perspectives
GlaxoSmithKline plc (GSK) PT Raised to GBX 1670 at JP Morgan Chase & Co  The Cerbat Gem
Beaufort Securities Breakfast Alert: Strat Aero, GlaxoSmithKline plc ...
"Federal Reserve Chairwoman Janet Yellen may be gearing up to raise short-term interest rates at March's FOMC policy meeting after all.
Market Risers: Capita PLC, GlaxoSmithKline plc, Hikma Pharmaceuticals Plc ...
Stock in GlaxoSmithKline plc ticker lookup code: LON:GSK has risen 1.22% or 19.5 points during the course of today's session so far.
GlaxoSmithKline plc 8.4% Potential Upside Indicated by Deutsche Bank
GlaxoSmithKline plc using EPIC/TICKER code LON:GSK has had its stock rating noted as 'Retains' with the recommendation being set at 'HOLD' this morning by analysts at Deutsche Bank.
Insider Trading at GlaxoSmithKline plc?  Sports Perspectives
5 Shares I'm Watching Today: Tesco PLC, Barclays PLC, GlaxoSmithKline ...  Investomania (blog)